Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Expert Rev Clin Pharmacol. 2017 Oct 12;11(2):151–164. doi: 10.1080/17512433.2017.1353909

Table 2.

Five of CYP2C19 phenotypes in clopidogrel metabolism based on genotypes.

Phenotype Examples of diplotypes

Ultrarapid metabolizer (UM) *17/*17
Increased enzyme activity compared to RM
Rapid metabolizer (RM) *1/*17
Increased enzyme activity compared to NM but less than UM
Normal metabolizer (NM) *1/*1
Fully functional enzyme activity
Intermediate metabolizer (IM) *1/*2, *1/*3, *2/*17
Decreased enzyme activity
Poor metabolizer (PM) *2/*2, *2/*3, *3/*3 or other combination of two LOF alleles (*2–*8)
Little to no enzyme activity

An individual carrying one functional allele (*1) plus one LOF allele (*2*8) or one LOF allele (*2*8) plus one increased-activity allele (*17). It seems that *17 allele is unable to completely compensate for reduced activity with the *2 allele, so *2/*17 is classified to IM.